Member Info for Mokomagic

Analysts have nudged their price target for Shield Therapeutics slightly higher, reflecting small adjustments to revenue growth, profit margin expectations, and the implied future P/E multiple. SP 17p.

Will the new proposal be passed today at the AGM /EGM???????????

Are people finally starting to see the value in STX?????

Have ECR indicated when their first clean up will take place? Weekly / monthly?????

PMSL Servalan, could not put it any better myself, Usually this will pick up this afternoon!! :)

Following an upward trajectory in 2025 and going into 2026 cashflow positive, we will see further investor sentiment improve as it did through the course of 2025. I look forward to seeing the share price move upwards / as they say its not a sprint its a marathon :)

Looking back at the RNS's 2025 results should be announced around the end of this month or Feb 2026

The IC has STX at a high of 23.18p and a medium of 14.96p based on one analysts target price.

Just doing some quick maths and looking back over the last three quarters revenue totalled $32.3 million US Dollars, if the upward trajectory continues in the Q4 say $14.00 million US dollars $900,000 above Q3's numbers then total revenue would be looking at $46.3 million US Dollars for 2025. This purely based on sales revenue alone.

To be honest, I think all shareholders will be waiting for the announcement in Jan 2026 to confirm that STX has become cashflow positive. I am no expert but am a long term holder of STX and based on recent announcements re new business and milestone payments due to STX under new agreements agreed, then in my humble opinion I do see that this will be the case based on the last 12 months performance and the final quarterly figures due to announced Jan 2026 for their financial year.

Analyst Price: Target Revision Analysts have maintained their price target for Shield Therapeutics at £0.16. This reflects confidence in the company's prospects, given stable fair value estimates and consistent growth expectations.

I see Peel Hunt has initiated coverage again with a SP of 15p

Deutsche Bank reiterated its 'buy' rating with a 12-month price target of 40p following the company’s trading update on Monday.

Given this mornings RNS, is it proven that the Kodiak and Aphun fields can produce oil and gas as previously stated? What is the the timeline for these to be up and running and producing oil and gas?

To be honest I understand people wanting to make a quick buck out of Pantheon Resources, but people need to look at the bigger picture here. I.e . The LNG opportunity etc... this doesn't happen overnight it takes time. Its also based on sentiment too and what people think the SP is worth!!! :D

On the upside if the results are positive re flow rates top end of 2000, can this possibly be more? 4 yrs ago I remember when the SP was 37p then it accelerated up to £1.44.

Shell are in discussions to potentially by BP : D

The share price has risen 333% in the last six months!!!!!!!!!

Let the flow tests speak for themselves LOL. :D

People just need to see the value in STX, just a slow burner until the momentum kicks in!!! :D